-+ 0.00%
-+ 0.00%
-+ 0.00%

OBSIDIAN THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN THE REGISTRATION-ENABLING COHORT OF PHASE 1/2 AGNI-01 STUDY EVALUATING AMSOKI-CEL (OBX-115) IN ADVANCED MELANOMA

Reuters·08/05/2026 11:05:00

Please log in to view news